Literature DB >> 2512447

Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.

M Taniike1, K Inui, Y Hirabayashi, H Tsukamoto, J Nishimoto, M Midorikawa, S Okada, H Yabuuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2512447     DOI： 10.1007/bf03335426

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Detection of ganglioside GM2 in sera and tumor tissues of hepatoma patients.

Authors:  H Higashi; Y Hirabayashi; M Hirota; M Matsumoto; S Kato
Journal:  Jpn J Cancer Res       Date:  1987-12

2.  Ultrastructural studies of eight cases of fetal Tay-Sachs disease.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Lab Invest       Date:  1974-01       Impact factor: 5.662

3.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

4.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.

Authors:  K Inui; D A Wenger
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.